期刊文献+

动力相关蛋白-1(MRP-1/CD9)对卵巢癌细胞体外增殖和运动的影响 被引量:1

The Effect of MRP-1/CD9 on Cell Proliferation and Motility of Human Ovarian Cancer Cell Lines in Vitro
下载PDF
导出
摘要 目的:动力相关蛋白-1(MRP-1/CD9)是四跨膜蛋白超家族(transmembrane4,superfamily,TM4SF)成员之一,参与调控细胞的生长、分化、细胞间粘附和迁移。本实验旨在研究MRP-1/CD9对人卵巢癌SKOV-3细胞株体外增殖和运动能力的影响并探讨其与PI4K/AKT信号通路的相关性。方法:应用RT-PCR获得CD9全长cDNA片段,正向插入pcDNA3.1表达载体,将重组质粒导入SKOV-3细胞中;应用RT-PCR、cfse-流式细胞测定和单层伤口愈合实验等方法观察转染前后SKOV-3细胞PI4K和AKTmRNA表达水平,细胞增殖及其运动能力变化。结果:成功构建正义全长CD9真核表达载体,获得稳定表达CD9的SKOV-3克隆株。与空质粒转染和不转染的SKOV-3细胞相比,SKOV-3/CD9细胞PI4KmRNA的表达明显被抑制,抑制率为40%;AKTmRNA的表达水平上调3.13倍,细胞增殖和运动能力均有明显升高。结论:CD9促进人卵巢癌SKOV-3细胞的体外增殖和运动能力,可能是通过PI4K/AKT信号通路发挥作用的,对卵巢癌恶性进展发挥重要作用。 Objective:To investigate the effects of transfecting the MRP-1/CD9 gene into the human ovarian careinoma cell line SKOV-3 on tumor cell proliferation and motility and to observe the relationship between CD9 and the PI4K/AKT signaling pathway.Methods:Full-length cDNA was obtained for CD9 using RT-PCR and was inserted into the peDNA3.1 expression veetor,The reconbinant plasmid was introduced into the SKOV-3cells RT-PCR,CFSE-flow cytometry and moostratal wound healing were used to detemine the expression levels of PI4K and AKT.cell proliferation and mtility of the SKOV-3cells,respeetively,before and after the transfection,Resultss:The eukaryotic expression vector was constructed successfully and clones with stable overexpression of CD9 were obtained,Compared with mock plasmid-transfeeted and untransfected cells,the mRNA expression of the PI4K gene was signifcantly inhibited by 40% and AKT mRNA expression was upregulated 3.13-fold in cells containing the CD9expression vector.Both tumor cell proliferation and cell motility were notably enhanced in SKOV-3/CD9 cell clones.Conclusion:CD9 overexpression increased cell proliferation and motility of SKOV-3 cells,and these functions may be induced by activating the PI4K/AKT signaling pathway. This study suggests overexpression of CD9 is associated with a more malignant progression in ovarian carcinoma.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2006年第24期1381-1385,共5页 Chinese Journal of Clinical Oncology
基金 国家自然科学基金(编号:C03020705) 国家重点基础研究发展规划"973"项目资助(编号:2002CB513107)
关键词 动力相关蛋白-1 卵巢癌 细胞增殖 细胞运动 Motility related protein-1 Ovarian carcinoma Cell proliferation Cell motility
  • 相关文献

参考文献10

  • 1Maecker HT,Todd SC,Levy S.The tetraspanin superfamily:molecular facilitators[J].FASEB J,1997,11(6):428~442
  • 2Funakoshil T,Tachibana I,Hoshida Y,et al.Expression of tetraspanins in human lung cancer cells:frequent downregulation of CD9 and its contribution to cell motility in small cell lung cancer[J].Oncogene,2003,22(5):674~687
  • 3Hori H,Yano S,Koufuji K,et al.CD9 Expression in Gastric Cancer and Its Significance[J].J Surg Res,2004,117(2):208~215
  • 4Sauer G,Windisch J,Kurzeder C,et al.Progression of Cervical Carcinomas Is Associated with Down-Regulation of CD9 But Strong Local Re-expression at Sites of Transendothelial Invasion[J].Clin Cancer Res,2003,9(17):6426~6431
  • 5Zvieriev V,Wang JC,Chevrette M.Over-expression of CD9 does not affect in vivo tumorigenic or metastatic properties of human prostate cancer cells[J].Biochem Biophys Res Commun,2005,337(2):498~504
  • 6Valster A,Tran NL,Nakda M,et al.Cell migration and invasion assays[J].Methods,2005,37(2):208~215
  • 7Furuya M,Kato H,Nishimura N,et al.Down-regulation of CD9 in Human Ovarian Carcinoma Cell Might Contribute to Peritoneal Dissemination:Morphologic Alteration and Reduced Expression of B1 Integrin Subsets[J].Cancer Res,2005,65 (7):2617~2625
  • 8Gesierich S,Paret C,Hildebrand D,et al.Colocalization of the Tetraspanins,CO-029 and CD151,with Integrins in Human Pancreatic Adenocarcinoma:Impact on Cell Motility[J].Clin Cancer Res,2005,11(8):2840~2852
  • 9Hemler ME.Tetraspanin functions and associated microdomains[J].Nat Rev Mol Cell Biol,2005,6(10):801~811
  • 10Larue L,Bellacosa A.Epithelial-mesenchymal transition in development and cancer:role of phosphatidylinositol 3' kinase/AKT pathways[J].Oncogene,2005,24(50):7443~7454

同被引文献10

  • 1Murata S, Kawahara H, Tohma S, et al. Growth retardation in mice lacking the proteasome activator PA28gamma[J]. J Biol Chem, 1999, 274(53):38211-38215.
  • 2Barton LF, Runnels HA, Schell TD, et al. Immune defects in 28-kDa proteasome activator gammadeficient mice[]]. J Immunol, 2004, 172(6):3948-3954.
  • 3Masson P, LundgrenJ, Young P. Drosophila proteasome regulator REGgamma:transcriptional activation by DNA replication-related factor DREF and evidence for a role in cell cycle progression[J].J Mol Biol, 2003, 327(5): 1001-1012.
  • 4Li X, Amazit L, Long W, et al. Ubiquitin-and ATP-independent proteolytic turnover of p21 by the REGgamma-proteasome pathway[J].Mol Cell, 2007, 26(6): 831-842.
  • 5Chen X, Barton LF, Chi Y, et al. Ubiquitin-independent degradation of cell-cycle inhibitors by the REGgamma proteasome[J].Mol Cell, 2007, 26(6): 843-852.
  • 6Yi T, BaekJ-H, Kim HJ, et al. Trichostatin A-mediated upregulation of p21(WAF1) contributes to osteoclast apoptosis[J]. Exp Mol Med, 2007, 39(2): 213-221.
  • 7Lee CJ, Kim HT, Song KW, et al. Ovarian expression of p53 and p21 apoptosis regulators in gamma-irradiated mice[J]. Mol Reprod Dev, 2008, 75(2): 383-391.
  • 8Obradovic D, Tirard M, N6methy Z, et al. DAXX, FLASH, and FAF-1 modulate mineralocorticoid and glucocorticoid receptor-mediated transcription in hippocampal cells-toward a basis for the opposite actions elicited by two nuclear receptors[J].? Mol Pharmacol, 2004, 65(3): 761-769.
  • 9Zhang Z, Zhang R. Proteasome activator PA28 gamma regulates p53 by enhancing its MDM2-mediated degradation[J]. EMBOJ, 2008, 27(6): 852-864.
  • 10J 萨姆布鲁克,D W 拉塞尔.分子克隆实验指南[M].第3版.北京:科学出版社,2002:304-340.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部